Table 2

Expression of markers and survival.

Tumor

Peritumoral capsule


Marker expression

Patients (n)

Patients (%)

Median survival (months)

5-Year survival (%)

P

Patients (n)

Patients (%)

Median survival (months)

5-Year survival (%)

P


CD 3

Low

56

70

80

54

0.207

29

36

32

47

0.756

High

19

24

27

36

40

50

67

56

Missing

5

6

11

14

CD 4

Low

64

80

57

49

0.887

45

56

52

51

0.654

High

14

18

27

50

35

44

57

53

Missing

2

3

10

12

CD 8

Low

64

80

80

54

0.198

47

59

67

52

0.838

High

14

18

15

36

26

32

38

50

Missing

2

3

7

9

CD 20

Low

56

70

63

50

0.880

65

81

75

55

0.032

High

22

28

32

50

12

15

13

33

Missing

2

3

3

4


Peritumoral capsule lymphocyte subsets and their prediction for disease-specific survival in patients with soft tissue sarcomas (univariate analysis; log-rank test), N = 80

Sorbye et al. BMC Clinical Pathology 2012 12:5   doi:10.1186/1472-6890-12-5

Open Data